-
- South Korea / 2000
FREND COVID-19 IgG/IgM Duo
- ◾ Price: Negotiable
- ◾ MOQ: Negotiable
FREND COVID-19 IgG/IgM Duo
- ◾ Price: Negotiable
- ◾ MOQ: Negotiable
-
Required Quantity
-
Brand name-
-
Shipping / Lead TimeNegotiable / Negotiable
-
Keyword
-
Category
Specifications
| Size | - | Weight | - | Stock | - |
|---|---|---|---|---|---|
| Country of Origin | South Korea | ||||
| Production method | Negotiable | ||||
Trade Terms
| Payment Terms | - | ||||
|---|---|---|---|---|---|
| Price(FOB) | Negotiable | MOQ | Negotiable | ||
| Transportation | - | ||||
| Lead time | Negotiable | Shipping time | Negotiable | ||
Company
-
Country / Year Established
-
Verified Certificate
-
18
-
-
18
-
Main Export Markets
-
Germany
-
Italy
-
Japan
-
Taiwan
-
United Kingdom
-
Product Description
The FREND™ COVID-19 IgG/IgM Duo is a point-of-care testing (POCT) which can be used to check whether patients have developed immune responses to SARS-CoV-2 using human serum or plasma.
- 3 minutes | Fast result
- 2 steps | Easy to use
- 93% & 100% | Positive & Negative Percent Agreement
- Microfluidic Qualitative Immunoassay
- LIS connectivity (data management)

With just simple steps of operation, the FREND™ system supports quick decision-making.

Effective Data Management







